Single-dose montelukast or salmeterol as protection against exercise-induced bronchoconstriction

Chest

Volumn 132, Issue 3, 2007, Pages 875-883

  Philip, George ^a   Pearlman, David S ^b   Villarán, César ^c   Legrand, Catherine ^a   Loeys, Tom ^a   Langdon, Ronald B ^a   Reiss, Theodore F ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Respiratory Institute   (United States)

^c CLÍNICA RICARDO PALMA   (Peru)

Author keywords

Bronchial asthma; Bronchospasm; Exercise induced bronchoconstriction; Leukotriene receptor antagonist; Long acting agonist; adrenergic receptor agonist

Indexed keywords

ACETIC ACID DERIVATIVE; ANTIASTHMATIC AGENT; BRONCHODILATING AGENT; DRUG DERIVATIVE; MONTELUKAST; QUINOLINE DERIVATIVE; SALBUTAMOL; SALMETEROL;

ADOLESCENT; ADULT; ARTICLE; BRONCHUS DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; METABOLISM; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; STENOSIS, OCCLUSION AND OBSTRUCTION;

ACETATES; ADOLESCENT; ADULT; ALBUTEROL; ANTI-ASTHMATIC AGENTS; BRONCHIAL DISEASES; BRONCHODILATOR AGENTS; CONSTRICTION, PATHOLOGIC; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; QUINOLINES;

EID: 35448992885     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.07-0550     Document Type: Article

References (42)

1. McFadden ER Jr, Gilbert IA. Exercise-induced asthma. N Engl J Med 1994; 330:1362-1367 (Pubitemid 24136061)
2. Hallstrand TS, Curtis JR, Koepsell TD, et al. Effectiveness of screening examinations to detect unrecognized exercise-induced bronchoconstriction. J Pediatr 2002; 141:343-348
3. Gotshall RW. Exercise-induced bronchoconstriction. Drugs 2002; 62:1725-1739 (Pubitemid 34948172)
4. Parsons JP, Mastronarde JG. Exercise-induced bronchoconstriction in athletes. Chest 2005; 128:3966-3974 (Pubitemid 43062659)
5. Anderson SD. Single-dose agents in the prevention of exercise- induced asthma: a descriptive review. Treat Respir Med 2004; 3:365-379
6. Anderson SD, Rodwell LT, Du Toit J, et al. Duration of protection by inhaled salmeterol in exercise-induced asthma. Chest 1991; 100:1254-1260
7. Serevent Diskus and Inhalation Aerosol [package inserts]. GlaxoSmithKline. Available at: http://us.gsk.com/products/ assets/us-serevent- diskus.pdf;
8. and http://us.gsk.com/products/ assets/us-serevent.pdf. Accessed February 15, 2007
9. Nelson JA, Strauss L, Skowronski M, et al. Effect of long- term salmeterol treatment on exercise-induced asthma. N Engl J Med 1998; 339:141-146 (Pubitemid 28328477)
10. Bisgaard H. Role of leukotrienes in asthma pathophysiology. Pediatr Pulmonol 2000; 30:166-176
11. Hallstrand TS, Moody MW, Wurfel MM, et al. Inflammatory basis of exercise-induced bronchoconstriction. Am J Respir Crit Care Med 2005; 172:679-686 (Pubitemid 41324221)
12. Manning PJ, Watson RM, Margolskee DJ, et al. Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist. N Engl J Med 1990; 323:1736-1739
13. Meltzer SS, Hasday JD, Cohn J, et al. Inhibition of exercise-induced bronchospasm by zileuton: a 5-lipoxygenase inhibitor. Am J Respir Crit Care Med 1996; 153:931-935 (Pubitemid 26081641)
14. Lehnigk B, Rabe KF, Dent G, et al. Effects of a 5-lipoxygenase inhibitor, ABT-761, on exercise-induced bronchoconstriction and urinary LTE4 in asthmatic patients. Eur Respir J 1998; 11:617-623 (Pubitemid 28194853)
15. Dessanges JF, Prefaut C, Taytard A, et al. The effect of zafirlukast on repetitive exercise-induced bronchoconstriction: the possible role of leukotrienes in exercise-induced refractoriness. J Allergy Clin Immunol 1999; 104:1155-1161 (Pubitemid 30004973)
16. Pearlman DS, Ostrom NK, Bronsky EA, et al. The leukotriene D4-receptor antagonist zafirlukast attenuates exercise-induced bronchoconstriction in children. J Pediatr 1999; 134:273-279 (Pubitemid 30417633)
17. O'Byrne PM. Leukotriene bronchoconstriction induced by allergen and exercise. Am J Respir Crit Care Med 2000; 161:S68-S72 (Pubitemid 30129419)
18. Moraes TJ, Selvadurai H. Management of exercise-induced bronchospasm in children: the role of leukotriene antagonists. Treat Respir Med 2004; 3:9-15 (Pubitemid 38444327)
19. Villaran C, O'Neill SJ, Helbling A, et al. Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. J Allergy Clin Immunol 1999; 104:547-553 (Pubitemid 29451642)
20. Edelman JM, Turpin JA, Bronsky EA, et al. Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. Ann Intern Med 2000; 132:97-104 (Pubitemid 30044175)
21. Steinshamn S, Sandsund M, Sue-Chu M, et al. Effects of montelukast and salmeterol on physical performance and exercise economy in adult asthmatics with exercise-induced bronchoconstriction. Chest 2004; 126:1154-1160 (Pubitemid 39391245)
22. 2-agonists, leukotriene receptor antagonists, and a 5-lipoxygenase inhibitor on exercise-induced asthma. J Allergy Clin Immunol 2000; 106:500-506
23. Coreno A, Skowronski M, West E, et al. Bronchoprotective effects of single doses of salmeterol combined with montelukast in thermally induced bronchospasm. Chest 2005; 127: 1572-1578 (Pubitemid 46218781)
24. Pearlman DS, van Adelsberg J, Philip G, et al. Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast. Ann Allergy Asthma Immunol 2006; 97:98-104 (Pubitemid 44156345)
25. Philip G, Pearlman DS, Villaran C, et al. Protection against exercise-induced bronchoconstriction by a single, oral dose of montelukast. J Asthma 2007; 44:213-217 (Pubitemid 46598156)
26. Bronsky EA, Kemp JP, Zhang J, et al. Dose-related protection of exercise bronchoconstriction by montelukast, a cysteinyl leukotriene-receptor antagonist, at the end of a once-daily dosing interval. Clin Pharmacol Ther 1997; 62:556-561 (Pubitemid 28214933)
27. Zhao JJ, Rogers JD, Holland SD, et al. Pharmacokinetics and bioavailability of montelukast sodium (MK-0476) in healthy young and elderly volunteers. Biopharm Drug Dispos 1997; 18:769-777 (Pubitemid 27517566)
28. Leff JA, Busse WW, Pearlman D, et al. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med 1998; 339:147-152 (Pubitemid 28328478)
29. Bauer P. Multiple testing in clinical trials. Stat Med 1991; 10:871-889
30. Senn S. Cross-over trials in clinical research. Hoboken, NJ: Wiley, 1993
31. Newcombe RG. Improved confidence intervals for the difference between binomial proportions based on paired data. Stat Med 1998; 17:2635-2650 (Pubitemid 28510655)
32. Mannix ET, Manfredi F, Farber MO. A comparison of two challenge tests for identifying exercise-induced bronchospasm in figure skaters. Chest 1999; 115:649-653 (Pubitemid 29129939)
33. National Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma, expert panel report 2 and update on selected topics 2002. Available at: http://www.nhlbi.nih.gov/guidelines/asthma. Accessed April 30, 2007
34. Peroni DG, Piacentini GL, Ress M, et al. Time efficacy of a single dose of montelukast on exercise-induced asthma in children. Pediatr Allergy Immunol 2002; 13:434-437 (Pubitemid 36069955)
35. Edmunds AT, Tooley M, Godfrey S. The refractory period after exercise-induced asthma: its duration and relation to the severity of exercise. Am Rev Respir Dis 1978; 117:247-254 (Pubitemid 8319021)
36. de Benedictis FM, Del Giudice MM, Forenza N, et al. Lack of tolerance to the protective effect of montelukast in exercise- induced bronchoconstriction in children. Eur Respir J 2006; 28:291-295 (Pubitemid 44914226)
37. Ramage L, Lipworth BJ, Ingram CG, et al. Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol. Respir Med 1994; 88:363-368 (Pubitemid 24167105)
38. Garcia R, Guerra P, Feo F, et al. Tachyphylaxis following regular use of formoterol in exercise-induced bronchospasm. J Investig Allergol Clin Immunol 2001; 11:176-182 (Pubitemid 34226383)
39. 2-agonist tolerance and exercise-induced bronchospasm. Am J Respir Crit Care Med 2002; 165:1068-1070
40. Storms W, Chervinsky P, Ghannam AF, et al. A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge. Respir Med 2004; 98:1051-1062 (Pubitemid 39317934)
41. Salpeter SR, Buckley NS, Ormiston TM, et al. Meta-analysis: effect of long-acting β-agonists on severe asthma exacerbations and asthma-related deaths. Ann Intern Med 2006; 144:904-912 (Pubitemid 46768131)
42. 2-agonists and exercise-induced asthma. Clin Rev Allergy Immunol 2006; 31:163-180